Skip to main content

Market Overview

AstraZeneca Looking At Potential Options for COVID-19 Vaccine Business: Reuters

Share:
AstraZeneca Looking At Potential Options for COVID-19 Vaccine Business: Reuters
  • AstraZeneca plc (NASDAQ: AZNis reportedly exploring its options for the future of its COVID-19 vaccine business.
  • The Company expects clarity on the matter by the end of 2021.
  • "We are exploring different options," Ruud Dobber, executive vice president and president of BioPharmaceuticals Business Unit, told Reuters about the vaccines business.
  • The Company generated around $894 million from COVID-19 vax sales in Q2.
  • Price Action: AZN shares are up 1.6% at $57.70 during the premarket session on the last check Thursday.
  • Image by Wilfried Pohnke from Pixabay
 

Related Articles (AZN + AZNCF)

View Comments and Join the Discussion!

Posted-In: Briefs COVID-19 VaccineBiotech M&A News Health Care Rumors General Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com